Literature DB >> 29100854

White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.

Nidhi Gupta1, Alexis N Simpkins1, Emi Hitomi1, Christian Dias1, Richard Leigh2.   

Abstract

BACKGROUND: White matter hyperintensities (WMH), the hallmark of vascular cognitive impairment, are associated with vascular risk factors (VRF). WMH can also be associated with blood-brain barrier (BBB) disruption. The purpose of this study was to look for associations between VRF and BBB disruption in stroke patients with WMH.
METHODS: Magnetic resonance images of stroke patients were reviewed for the presence of WMH. Blood-brain permeability images were retrospectively generated. The degree of BBB permeability was compared with the presence of VRF using logistic regression. Patterns and extent of WMH were classified using Fazekas scores.
RESULTS: Sixty-five patients were included in this study. None of the VRF tested were associated with an increase in BBB disruption. Hypertension was significantly associated with less BBB disruption (P = .04). Nonhypertensive patients in our study had a different pattern of WMH than hypertensive patients, with less involvement of the periventricular white matter.
CONCLUSIONS: We found that in stroke patients with WMH, those with hypertension had less BBB disruption and greater involvement of the periventricular white matter when compared with patients who did not have a history of hypertension. Further investigation is needed to determine if the development of WMH in stroke patients with a history of hypertension has a different pathophysiology from patients who develop WMH in the absence of hypertension. Published by Elsevier Inc.

Entities:  

Keywords:  White matter hyperintensities; blood–brain barrier; hypertension; permeability imaging; vascular cognitive impairment

Mesh:

Year:  2017        PMID: 29100854      PMCID: PMC5808404          DOI: 10.1016/j.jstrokecerebrovasdis.2017.09.026

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  23 in total

1.  Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study.

Authors:  A Spilt; R Goekoop; R G J Westendorp; G J Blauw; A J M de Craen; M A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

2.  Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals.

Authors:  H Lechner; R Schmidt; G Bertha; E Justich; H Offenbacher; G Schneider
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

3.  Periventricular cerebral white matter lesions predict rate of cognitive decline.

Authors:  Jan Cees De Groot; Frank-Erik De Leeuw; Matthijs Oudkerk; Jan Van Gijn; Albert Hofman; Jellemer Jolles; Monique M B Breteler
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

4.  Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.

Authors:  Alexis N Simpkins; Christian Dias; Richard Leigh
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

5.  Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Rebecca F Gottesman; Josef Coresh; Diane J Catellier; A Richey Sharrett; Kathryn M Rose; Laura H Coker; Dean K Shibata; David S Knopman; Clifford R Jack; Thomas H Mosley
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

6.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

7.  Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity in human gliomas.

Authors:  Anne Kluge; Mathias Lukas; Vivien Toth; Thomas Pyka; Claus Zimmer; Christine Preibisch
Journal:  Magn Reson Imaging       Date:  2015-12-17       Impact factor: 2.546

Review 8.  Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Authors:  Gary A Rosenberg; Maria Bjerke; Anders Wallin
Journal:  Stroke       Date:  2014-04-01       Impact factor: 7.914

9.  Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage.

Authors:  Richard Leigh; Søren Christensen; Bruce C V Campbell; Michael P Marks; Gregory W Albers; Maarten G Lansberg
Journal:  Neurology       Date:  2016-06-17       Impact factor: 9.910

10.  Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients.

Authors:  Richard Leigh; Shyian S Jen; Daniel D Varma; Argye E Hillis; Peter B Barker
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more
  10 in total

1.  Severe tardive dyskinesia induced by domperidone in presenile and non-dementia type 2 diabetes man with alcohol misuse showing albuminocytological dissociation and white matter hyperintensity.

Authors:  Akinori Kanzaki; Hidetoshi Tada; Akihito Otsuka; Tadashi Nakamura
Journal:  BMJ Case Rep       Date:  2019-05-29

2.  Show Me Your White Matter, I Will Tell You Who You Are ….

Authors:  Gregory Kuchcinski; Clinton B Wright
Journal:  Stroke       Date:  2021-01-07       Impact factor: 7.914

3.  MTT and Blood-Brain Barrier Disruption within Asymptomatic Vascular WM Lesions.

Authors:  B E Dewey; X Xu; L Knutsson; A Jog; J L Prince; P B Barker; P C M van Zijl; R Leigh; P Nyquist
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-03       Impact factor: 4.966

4.  COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure.

Authors:  Mohani-Preet K Bajaj; Daniel R Burrage; Andrew Tappouni; James W Dodd; Paul W Jones; Emma H Baker
Journal:  Clin Interv Aging       Date:  2018-12-18       Impact factor: 4.458

5.  Lenticulostriate Arteries and Basal Ganglia Changes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, a High-Field MRI Study.

Authors:  Chen Ling; Xiaojing Fang; Qingle Kong; Yunchuang Sun; Bo Wang; Yan Zhuo; Jing An; Wei Zhang; Zhaoxia Wang; Zihao Zhang; Yun Yuan
Journal:  Front Neurol       Date:  2019-08-09       Impact factor: 4.003

Review 6.  Neuroimaging of Cerebral Small Vessel Disease and Age-Related Cognitive Changes.

Authors:  Michelle R Caunca; Andres De Leon-Benedetti; Lawrence Latour; Richard Leigh; Clinton B Wright
Journal:  Front Aging Neurosci       Date:  2019-06-27       Impact factor: 5.750

Review 7.  The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review.

Authors:  Jing Sun; Baofeng Xu; Xuejiao Zhang; Zhidong He; Ziwei Liu; Rui Liu; Guangxian Nan
Journal:  Front Public Health       Date:  2020-11-17

8.  Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans.

Authors:  Fanny M Elahi; Danielle Harvey; Marie Altendahl; Nivetha Brathaban; Nicole Fernandes; Kaitlin B Casaletto; Adam M Staffaroni; Pauline Maillard; Jason D Hinman; Bruce L Miller; Charles DeCarli; Joel H Kramer; Edward J Goetzl
Journal:  Sci Rep       Date:  2021-08-10       Impact factor: 4.379

9.  "Liquid Biopsy" of White Matter Hyperintensity in Functionally Normal Elders.

Authors:  Fanny M Elahi; Kaitlin B Casaletto; Marie Altendahl; Adam M Staffaroni; Evan Fletcher; Teresa J Filshtein; Maria M Glymour; Bruce L Miller; Jason D Hinman; Charles DeCarli; Edward J Goetzl; Joel H Kramer
Journal:  Front Aging Neurosci       Date:  2018-11-09       Impact factor: 5.750

10.  Transcriptomic Analysis of Age-Associated Periventricular Lesions Reveals Dysregulation of the Immune Response.

Authors:  Motaz M Fadul; Paul R Heath; Johnathan Cooper-Knock; Julian M Kurz; Hayder A Al-Azzawi; Zarki Ali; Taylor Smith; Fiona E Matthews; Carol Brayne; Stephen B Wharton; Julie E Simpson
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.